글로벌 유리체망막질환 시장 – 2029년까지의 산업 동향 및 예측

유리체망막질환 시장 분석 및 규모

글로벌 유리체망막질환 시장은 예측 기간 동안 상당한 성장을 보일 것으로 예상됩니다. 당뇨병과 안구 질환의 증가가 유리체망막질환 시장을 주도합니다. 환경 오염, 안과 질환에 대한 가족력 및 건강에 해로운 생활 방식 채택으로 인해 유리체망막질환 시장 성장이 촉진됩니다. COVID-19도 시장 성장에 큰 영향을 미쳤습니다.

 Data Bridge Market Research는 2022-2029년 예측 기간 동안 글로벌 유리체망막 장애 시장의 성장률을 분석합니다. 글로벌 유리체망막 장애 시장의 예상 CAGR은 언급된 예측 기간 동안 약 8%인 경향이 있습니다. 이 시장은 2021년에 16억 달러로 평가되었으며 2029년까지 29억 6천만 달러까지 성장할 것입니다. Data Bridge Market Research 팀이 큐레이팅한 시장 보고서에는 시장 가치, 성장률, 시장 세그먼트, 지리적 범위, 시장 참여자 및 시장 시나리오와 같은 시장 통찰력 외에도 심층적인 전문가 분석, 환자 역학, 파이프라인 분석, 가격 분석 및 규제 프레임워크가 포함되어 있습니다.

시장 정의

유리체망막 장애는 망막, 황반부, 유리체액을 포함한 눈의 주요 구조에 영향을 미칩니다. 망막은 눈의 뒤쪽에 있는 빛에 민감한 층으로, 이미지를 초점을 맞추고 시신경으로 정보를 전달하는 데 도움이 됩니다. 유리체는 렌즈와 망막 사이의 공간을 채우는 젤과 같은 액체입니다. 망막 세포와 유리체액의 퇴화는 유리체망막 장애를 일으킵니다. 유리체망막 장애의 증상에는 통증이 없는 편측 부유물 및/또는 시력 상실, 근시, 백내장 등이 있습니다.

유리체망막질환 시장 범위 및 세분화

글로벌 유리체망막질환 시장 동향

운전자

• 노인 인구 증가

글로벌 유리체망막질환 시장은 인구 고령화로 인해 예측 기간 동안 큰 성장률을 보일 것으로 예상됩니다. 글로벌 백내장 시장의 수요 증가는 60세 이상의 사람들이 눈의 탄력성이 감소하고 정상적인 기능에 영향을 미치는 질환을 자주 앓기 때문에 노인 인구가 증가하는 것을 반영한 것입니다. 이로 인해 시장 성장이 촉진됩니다.

• 전략적 조치 및 임상 연구 증가

신제품 출시와 같은 상승 전략은 주요 시장 참여자가 다른 참여자에 비해 경쟁 우위를 확보하는 데 도움이 될 수 있습니다. 예를 들어, DORC는 2021년 1월에 Health Canada로부터 TissueBlue 0.025%의 적용에 대한 승인을 받았습니다. 이는 인도시아닌 그린 및 기타 여과제의 대안으로 사용될 것입니다. 이는 시장 성장을 촉진합니다.

기회

• 상승하는 정부 이니셔티브

The growing adoption of initiatives, policies, and programs by the government authorities and many public organizations is improving the access to affordable vision care and this is anticipated to drive the market size. For instance, the International Agency for the Prevention of Blindness launched VISION 2020 with the aim to accelerate the prevention of blindness activities. The program included the World Sight Day which is an initiative that helps in the promotion of rising awareness associated with blindness and vision impairment.

• Increasing Demand for Retail Pharmacies

Rise in the number of vitreoretinal disorders therapeutics being delivered through retail pharmacies and surge in the number of retail pharmacies in developed countries create opportunities for the market growth. In addition to this, patients prefer retail pharmacies for purchasing drugs, as these are easily accessible.

 Restraints/Challenges

• Lack of skilled professionals

The lack of qualified personnel who are unable to treat the patients with appropriate treatments could curb the growth of the global vitreoretinal disorders market over a forecast period.

• High Cost

The huge expenditure associated with the treatment of vitreoretinal disorders surely hamper the market growth.

This global vitreoretinal disorders market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the global vitreoretinal disorders market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

COVID-19 Impact on Global Vitreoretinal Disorders Market           

The Covid-19 pandemic greatly affected the market due to reduction in number of patient visits in hospitals and clinics for vitreoretinal disorders and interruption of numerous alternative procedures and outpatient visits. Although, the market is expected to recover with continuation of activities across various domains and approval and administration of Covid-19 vaccines.

Global Vitreoretinal Disorders Market Scope

The global vitreoretinal disorders market is segmented on the basis of type, diagnosis, treatment, distribution channel, route of administration and end-user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Type

• Retinal Tear
• Retinal Detachment
• Diabetic Retinopathy
• Macular Degeneration
• Macular Hole
• Others

Diagnosis

• Digital fluorescein Angiography
• Optical Coherence Tomography
• Heidelberg Retinal Tomography
• Indocyanine Green Angiography
•  Others

Treatment

• Surgery
• Medication
• Others

Route of Administration

• Oral
• Parenteral
• Ocular
• Others

End User

• Hospitals
• Homecare
• Specialty Clinics
• Others

Distribution Channel

• Hospital Pharmacy
• Online Pharmacy
• Retail Pharmacy

Global Vitreoretinal Disorders Market Regional Analysis/Insights

The global vitreoretinal disorders market is analysed and market size insights and trends are provided by type, diagnosis, treatment, distribution channel, route of administration and end-user as referenced above.

The major countries covered in the global vitreoretinal disorders market report are the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

Asia-Pacific has been witnessing a positive growth for global vitreoretinal disorders market throughout the forecasted period due to increased government awareness programs, rising population of affluent patients and number of generic drugs.

North America dominates the market due to the improved medical reimbursement structure, high research and development and healthcare expenditure and skilled professionals.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.   

Competitive Landscape and Global Vitreoretinal Disorders Market Share Analysis

The global vitreoretinal disorders market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to global vitreoretinal disorders market.

Key players operating in the global vitreoretinal disorders market include:

• Aerie Pharmaceuticals, Inc. (U.S.)
• Allergan (Ireland)
• Bausch Health (U.S.)
• Merck & Co. Inc. (U.S.)
• Pfizer Inc. (U.S.)
• Teva Pharmaceutical Industries Ltd. (Israel)
• Alcon (Switzerland)
• Astellas Pharma Inc. (Japan)
• Bayer AG(독일)
• 노바티스 AG(스위스)
• 아스트라제네카(영국)
• 암젠 주식회사(미국)
• Carl Zeiss Meditec AG(독일)
• HumanOptics Holding AG(독일)
• STAAR SURGICAL(미국)

SKU-53882